EF
RIGL icon

Empowered Funds’s Rigel Pharmaceuticals RIGL Stock Holding History

Empowered Funds’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Sell
79,184
-3,439
-4% -$106K 0.02% 952
2026
Q1 		$2.23M Buy
+82,623
New +$2.78M 0.01% 1048

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's RIGL Position: Q2 2026 in Review

Empowered Funds reduced its Rigel Pharmaceuticals (RIGL) stake by 4.2% in Q2 2026, selling an estimated $106K and leaving 79,184 shares worth $3.1M. The position accounts for 0.02% of the portfolio, ranked #952.

Empowered Funds first reported a position in RIGL in Q1 2026 and has held it in 2 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Empowered Funds held 79,184 shares of Rigel Pharmaceuticals worth $3.1M as of Q2 2026.
  • Empowered Funds sold 3,439 Rigel Pharmaceuticals shares in Q2 2026, an estimated $106K.
  • Rigel Pharmaceuticals made up 0.02% of Empowered Funds's portfolio in Q2 2026, its #952 holding.
  • Empowered Funds first reported a position in Rigel Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.